Challenges in the Diagnosis of the Right Patient for Testosterone Replacement Therapy
|
|
- Horatio Curtis
- 8 years ago
- Views:
Transcription
1 european urology supplements 6 (2007) available at journal homepage: Challenges in the Diagnosis of the Right Patient for Testosterone Replacement Therapy Christina Wang * Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, CA, USA Article info Keywords: Androgen deficiency Diagnosis Hypogonadism Serum testosterone Testosterone deficiency syndrome Testosterone replacement therapy Please visit europeanurology to read and answer questions on-line. The EU-ACME credits will then be attributed automatically. Abstract Diagnosis of testosterone deficiency is important to identify patients who might benefit from testosterone replacement therapy. Unfortunately, the diagnosis of hypogonadism may be a challenge for many practicing physicians, including endocrinologists and urologists. Signs and symptoms, such as sexual dysfunction, change in body composition, lethargy, and mood changes, are nonspecific and the available questionnaires are generally not useful in clinical practice. The diagnosis of testosterone deficiency is ultimately based on measurement of serum testosterone levels. However, marked variations in the reference ranges of serum testosterone levels among laboratories pose a challenge for physicians when interpreting the results. In addition, initial laboratory assessments usually determine total testosterone levels. About 1 2% of total testosterone is free and a further 30 50% is bound with low affinity to albumin; only these two components are bioavailable to the target tissues. In general, assuming the normal reference range for serum total testosterone in adult men is ng/dl (10 35 nmol/l), levels of < 250 ng/dl (8.7 nmol/l) suggest the patient is likely to be hypogonadal, whereas levels of > 350 ng/dl (12.7 nmol/l) suggest the symptoms may not be due to androgen deficiency. Values between 250 to 350 ng/dl warrant a repeat morning serum testosterone determination with assessment of free or bioavailable testosterone. In men with symptoms suggestive of androgen deficiency and borderline serum testosterone levels, where there are no contraindications to androgen therapy, a short therapeutic trial of testosterone may be justified. # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. * Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute, 1000 West Carson Street, Torrance, CA 90509, USA. Tel ; Fax: address: wang@labiomed.org. 1. Introduction The diagnosis of testosterone deficiency is important to identify patients who may benefit from testosterone replacement therapy. Numerous studies have shown that testosterone replacement can improve sexual function, muscle mass, bone density, body composition, mood, and energy in hypogonadal men [1,2]. A diagnosis of testosterone deficiency is based on a reproducibly low level of /$ see front matter # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi: /j.eursup
2 european urology supplements 6 (2007) Table 1 Signs and symptoms of androgen deficiency Decreased libido, erectile dysfunction Decreased muscle strength and mass (frailty) Decreased body hair and thinness of skin Decreased general well-being and mood changes Fractures and back pain (osteopenia) (frailty) Increased abdominal fat Decreased energy and work capacity (frailty) Gynecomastia serum testosterone, or its biologically active component, in association with signs and symptoms of androgen deficiency. In patients with severe testosterone deficiency, for example, due to diseases of the testes or pituitary, the diagnosis is usually straightforward. However, in the majority of hypogonadal patients with less severe testosterone deficiency without a definitive cause, the diagnosis remains a challenge [3]. 2. Signs and symptoms of androgen deficiency The common signs and symptoms of androgen deficiency include decreased libido and erectile dysfunction; reduced muscle strength and mass; back pain, low bone mass, and subsequent fractures (osteopenia); increased abdominal fat; loss of body hair and thinness of the skin; and an array of symptoms such as mood changes, lack of motivation, lethargy, decreased well-being, and poorer quality of life [4,5] (Table 1). At first glance, a diagnosis based on these signs and symptoms would appear to be relatively straightforward. However, closer examination reveals that they are all relatively nonspecific for testosterone deficiency. For example, as shown in Fig. 1, the pathogenesis of erectile dysfunction is multifactorial and, in addition to hypogonadism [6], it can be due to a combination of cardiovascular or neurologic problems or medication side effects leading to a defect in cavernosal release of nitric oxide. Thus, the presence of erectile dysfunction or decreased libido is not diagnostic for testosterone deficiency. Similarly, the changes in body composition that occur with testosterone deficiency, including an increase in body fat and a decrease in lean body mass, which may be associated with insulin resistance, are clearly not specific to androgen deficiency. Testosterone deficiency is a major cause of osteoporosis and deterioration of trabecular architecture in men [7]; around 5 30% of men with osteoporosis have no apparent cause other than hypogonadism. This lack of specificity for testosterone deficiency is even more obvious when considering symptoms such as depression or low vitality. Studies in older men suggest that depression was associated with lower bioavailable testosterone [8,9]. Randomized trials of testosterone replacement therapy have shown mixed results regarding efficacy in depression [10,11]. Testosterone deficiency is also associated with decreased vitality and quality of life. Epidemiologic studies have shown correlations between low testosterone and decreased energy, and energy is improved in most, although not all, studies of testosterone replacement therapy [12 14]. Nevertheless, symptoms such as depression and low vitality are associated with many conditions other than testosterone deficiency. Transient suppression of testosterone, and associated symptoms, can also occur with stress, and more prolonged testosterone deficiency occurs in a range of severe medical conditions such as HIV infection, chronic kidney disease, chronic obstructive airway disease, and cardiovascular disease [15]. Recent reports show that a substantial proportion of patients with type 2 diabetes mellitus with insulin resistance and visceral obesity have low testosterone levels [16 20]. Thus, hypogonadism should be excluded in patients with these chronic medical conditions, especially if they have associated symptoms such as sexual dysfunction. Fig. 1 Pathogenesis of erectile dysfunction.
3 864 european urology supplements 6 (2007) Questionnaires assessing androgen deficiency There are no specific validated questionnaires to diagnose androgen deficiency in younger men. A number of questionnaires are available to assess testosterone deficiency in older men, such as the Androgen Deficiency in Ageing Males (ADAM), the Aging Males Survey (AMS), and the Massachusetts Male Aging Study (MMAS) scales [21 23]. The sensitivity and specificity of the ADAM, MMAS, and AMS scales for hypogonadism were compared in 148 men (aged yr) with serum bioavailable testosterone of < 70 ng/dl [24]. As shown in Table 2, the sensitivity was relatively high, notably for the ADAM and AMS scales, but all three had low specificity. Unfortunately, because they have a low specificity, they are generally not very useful in clinical practice. A questionnaire that is more specific for hypogonadism has yet to be developed and may be helpful for the clinician, not only for diagnosis, but also for assessing the response to testosterone treatment. A recent study also found that an expanded modified version of the ADAM-AMS questionnaire did not improve the ability to identify patients with testosterone deficiency [3]. In addition to these questionnaires, a structured interview has been developed to screen for hypogonadism in men with sexual dysfunction. This 12- item interview, known as the ANDROTEST, has been shown to have a sensitivity of 68% and a specificity of 65% in detecting low total testosterone [25]. 4. Measurement of serum testosterone Ultimately, the diagnosis of testosterone deficiency, as the name implies, must be based on measurement of serum testosterone. Serum testosterone is relatively simple to measure, and most practicing physicians will determine total testosterone levels as the initial laboratory assessment. It should be noted that only about 1 2% of total testosterone is Table 2 Sensitivity and specificity of screening questionnaires for hypogonadism (defined as bioavailable testosterone < 70 ng/dl) [24] Sensitivity, % Specificity, % ADAM MMAS AMS ADAM = Androgen Deficiency in Ageing Males; MMAS = Massachusetts Male Aging Study; AMS = Aging Males Survey. Adapted from Morley et al. Maturitas 2006;53: Table 3 Serum total testosterone in a College of American Pathologists quality control sample (Y-04) measured using various different instruments/assays [26] No. of laboratories Median, ng/dl Range, ng/dl Abbott Architect Bayer ACS: Bayer Centaur Bayer Immuno Beckman Access/ Diagnostic Systems solid DPC Coat-a-Count DPC Immulite DPC Immulite Roche Elecsys/E Ortho Vitros ECi All instruments Adapted from Wang et al. J Clin Endocrinol Metab 2004;89: free, and a further 30 50% is bound with low affinity to albumin; therefore, only about 50% of total testosterone is bioavailable. Many different methods are available also for measuring testosterone (eg, direct radioimmunoassay, enzyme-linked immunoassays, chemiluminescent assays, radioimmunoassay after column extraction, and tandem mass spectrometry after high-performance liquid chromatography or gas chromatography). All of these methods are generally adequate for the diagnosis of male hypogonadism, but marked variations can occur from one laboratory to another. For example, an external quality control program carried out by the College of American Pathologists compared the results from 891 laboratories using 11 different assay methods [26]. The median serum total testosterone level measured in a single quality control sample ranged from 215 to 378 ng/dl among the various methods used, with the results from individual laboratories ranging from 160 to 508 ng/dl (Table 3). These results span the range between eugonadal and hypogonadal levels. This illustrates the importance of each laboratory establishing its own individual reference testosterone range for adult men for the diagnosis of hypogonadism. Studies have compared serum testosterone measurements by non-isotopic immunoassays, radioimmunoassay, gas chromatography-mass spectrometry, and liquid chromatography-tandem mass spectrometry [17,19,26]. These three studies, conducted in France, Australia, and the United States, indicated large variations in measurement of serum testosterone by different non-isotopic platform methods commonly used in clinical chemistry laboratories. In some methods, systematic bias gave higher or lower testosterone results when compared
4 european urology supplements 6 (2007) with methods using mass spectrometry. Most importantly, these studies showed that with the current methods commonly used in clinical laboratories, serum testosterone cannot be measured accurately and precisely in women and children. Most assays are adequate to distinguish eugonadal from hypogonadal men provided reference ranges are established in each individual laboratory. In a recent position statement by the Endocrine Society, it was concluded that laboratory testing should be based on the ability to measure samples containing known levels of testosterone, not only on agreement with other laboratories using the same method [27]. They also proposed that unified normative values should be established, if possible, for total and free testosterone. In the interim, before such uniform standards or methods can be implemented, the clinician should be aware of the type of assay the laboratory is using and the reference ranges. Based on the studies [17,19,26], the panel indicated that most of the current testosterone assays are adequate for the diagnosis of male hypogonadism. Clinicians should optimize the determination of serum testosterone levels by drawing the blood sample in the morning (between 7 and 10 AM). Although circadian rhythms in serum testosterone are less marked as men age, the reference ranges are usually obtained in the morning in younger men. In addition, physicians should check the reference range for serum testosterone in the laboratory they use to help them interpret the results. They should ask the laboratory how the reference ranges were determined; these should be established for each laboratory based on healthy younger men. In general, assuming that the normal reference range for serum total testosterone in adult men is ng/dl (10 35 nmol/l), levels of < 250 ng/dl (8.7 nmol/l) suggest that the patient is likely to be hypogonadal, whereas levels of >350 ng/dl (12.7 nmol/l) suggest that the symptoms may not be due to androgen deficiency. Note that some recent publications suggest using cut-off values of 200 and 400 ng/dl [28]. The International Society of Andrology (ISA), International Society for the Study of the Aging Male (ISSAM), and European Association of Urology (EAU) guidelines recommend that levels < 231 ng/dl (8 nmol/l) are representative of hypogonadism and that testosterone replacement may therefore be appropriate, and levels above a threshold of 346 ng/ dl (12 nmol/l) are normal [29]. Values between these limits warrant a repeat morning serum testosterone determination with direct measurement of free testosterone by equilibrium dialysis or calculated by measurements of sex hormone-binding globulin (SHBG) and total testosterone levels [30]. The guidelines from the Endocrine Society (United States) recommend that clinicians use the lower limit of the normal range for healthy young men that has been established in their reference laboratory [31].In some laboratories, this is 300 ng/dl (10.4 nmol/l). Free testosterone assays performed by many laboratories using analogue displacement give no additional information over total testosterone levels. Alternatively, direct measurement or calculated free or non SHBG-bound testosterone levels have been suggested to correlate better with symptoms of hypogonadism in elderly men. 5. Diagnosing the right patient for testosterone replacement therapy Fig. 2 summarizes the proposed steps in identifying the right patient for testosterone replacement Fig. 2 Diagnosis of patients suitable for testosterone replacement therapy. Modified with permission from Nieschlag et al. Eur Urol 2005;48:1 4 [29].
5 866 european urology supplements 6 (2007) therapy. If the patient has signs and symptoms of androgen deficiency, and morning serum total testosterone levels are < 250 ng/dl, then he is a candidate for testosterone replacement therapy. At this stage, luteinizing hormone (LH) and folliclestimulating hormone (FSH) levels should be checked; LH and FSH levels are elevated in primary hypogonadism but are normal or low in secondary hypogonadism. If testosterone, LH, and FSH levels are low, serum prolactin should be checked to exclude a prolactin-secreting pituitary tumor. Borderline levels of total testosterone should be followed up by measurement of free or bioavailable testosterone. If these levels are low, then the patient is a candidate for testosterone replacement therapy. In men with borderline serum testosterone levels, where there are no contraindications to androgen therapy, a short therapeutic trial of testosterone may also be justified with careful monitoring of any improvement in symptoms. There are many different methods of testosterone treatment and a decision can be reached between the patient and the physician [32]. 6. Conclusions Diagnosing testosterone deficiency and identifying suitable patients for testosterone replacement is a challenge for many practicing physicians. Measurement of serum testosterone remains the cornerstone for diagnosis, but physicians must be aware of the differences in accuracy and reference ranges between methods and laboratories. Patients with serum total testosterone levels of < 250 ng/dl and signs and symptoms of androgen deficiency are candidates for testosterone replacement therapy, whereas a short trial of testosterone replacement may be justified in those with borderline testosterone levels and symptoms suggestive of androgen deficiency. Conflicts of interest Research support from Solvay, GSK, Ardana, BMS, Indevus. Temporary consultant for Indevus, Bayer- Schering AG. References [1] Nieschlag E. Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol 2006;65: [2] Wang C, Swerdloff RS. Androgen replacement therapy in hypogonadal men. In: Winters SJ, editor. Male hypogonadism: basic, clinical and therapeutic principles. Totowa, NJ: Humana Press; p [3] Morales A, Spevack M, Emerson L, et al. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male 2007;10: [4] Liverman CT, Blazer DG. Testosterone and aging: clinical research directions. Washington, DC: National Academies Press; [5] Nieschlag E, Behre HM. Testosterone: action, deficiency, substitution. Cambridge, United Kingdom: Cambridge University Press; [6] Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007;52: [7] Benito M, Gomberg B, Wehrli FW, et al. Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab 2003;88: [8] Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 1999;84: [9] Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004;61: [10] Carnahan RM, Perry PJ. Depression in aging men: the role of testosterone. Drugs Aging 2004;21: [11] Pope HG, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160: [12] Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 2003;88: [13] Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89: [14] Wang C, Swedloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J Clin Endocrinol Metab 2000;85: [15] Handelsman DJ. Testicular dysfunction in systemic disease. Endocrinol Metab Clin North Am 1994;23: [16] Kapoor P, Luttrell BM, Williams D. The free androgen index is not valid for adult males. J Steroid Biochem Mol Biol 1993;45: [17] Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 2003;49:
6 european urology supplements 6 (2007) [18] Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003;6:1 7. [19] Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab 2005;90: [20] Betancourt-Albrecht M, Cunningham GR. Hypogonadism and diabetes. Int J Impot Res 2003;15(Suppl 4):S [21] Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W. A new aging males symptoms rating scale. Aging Male 1999;2: [22] Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49: [23] Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol 2000;53: [24] Morley JE, Perry III HM, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006;53: [25] Corona G, Mannucci E, Petrone L, et al. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 2006;3: [26] Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem spectrometry. J Clin Endocrinol Metab 2004;89: [27] Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society Position Statement. J Clin Endocrinol Metab 2007;92: [28] Araujo AB, O Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004;89: [29] Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Eur Urol 2005;48:1 4. [30] Accessed 24/04/07. [31] The Endocrine Society. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006;91: [32] Qoubaitary A, Swerdloff RS, Wang C. Advances in male hormone substitution therapy. Expert Opin Pharmacother 2005;6:
Current Data and Considerations Novel Testosterone Formulations
Current Data and Considerations Novel Testosterone Formulations 1 Diagnosis and Assessment Module 2 2 Objectives Identify clinical manifestations and symptoms of hypogonadism Describe components of comprehensive
More informationtestosterone_pellet_implantation_for_androgen_deficiency_in_men 10/2015 N/A 11/2016 10/2015 This policy is not effective until December 30, 2015
Corporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency in File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testosterone_pellet_implantation_for_androgen_deficiency_in_men
More informationCalcium. Table 1: Difference between method means in percent
Calcium Measurement of total calcium is widely used for both the diagnosis and the monitoring of a range of conditions related to the bones, heart, nerves, and kidneys. Total calcium measurements include
More informationMichael L. DeVan, 1 Daniel D. Bankson, 2 and Jude M. Abadie 1. Abstract
Clinical Chemistry / Measurable Free Testosterone Levels To What Extent Are Free Testosterone (FT) Values Reproducible Between the Two Washingtons, and Can Calculated FT Be Used in Lieu of Expensive Direct
More informationContinuity Clinic Educational Didactic. December 8 th December 12 th
Continuity Clinic Educational Didactic December 8 th December 12 th MKSAP Question 1 A 60-year-old man is evaluated for a 1-year history of generalized fatigue and lack of energy. He has had erectile dysfunction
More informationPrevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus
Prevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus Hypogonadism is defined as deficient or absent male gonadal function
More informationHypogonadism and Testosterone Replacement in Men with HIV
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Hypogonadism and Testosterone Replacement in Men with HIV Stephanie T. Page, MD, PhD Robert B. McMillen Professor in Lipid Research, Associate Professor of
More informationTestosterone Treatment in Older Men
Testosterone Treatment in Older Men J. Bruce Redmon, M.D. Professor Division of Endocrinology Departments of Medicine and Urologic Surgery Disclosure Information I have no financial relationships to disclose.
More informationTestosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division
Testosterone Replacement Therapy Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division Lecture Outline 1. Anatomy and physiology 2. Definition and etiology 3. Signs and symptoms
More informationTestosterone: Is Just for the GOP?
Testosterone: Is Just for the GOP? Brad Anawalt, MD Vice Chair and Professor of Medicine University of Washington May 1, 2015 banawalt@medicine.washington.edu Testosterone continuum Severe hypogonadism
More informationTestosterone in Old(er) Men
Testosterone in Old(er) Men Disclosure Information J. Bruce Redmon, M.D. Associate Professor Division of Endocrinology I have no financial relationships to disclose. I will not discuss off label use and/or
More informationBIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE
Authoriser: Moya O Doherty Page 1 of 7 BIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE The purpose of this protocol is to describe common tests used for the investigation
More informationA list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke
More informationMen Sexual Dysfunction Associated with Obesity and Metabolic Syndrome
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual
More informationShalender Bhasin, MD. Glenn R Cunningham, MD. Mohit Khera, MD, MBA, MPH
Shalender Bhasin, MD Program Chair Professor of Medicine Boston University School of Medicine Section Chief Division of Endocrinology, Diabetes & Nutrition Boston, MA Glenn R Cunningham, MD Professor of
More informationTestosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS
Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS The faces of Low Testosterone What your patients are seeing Pharmacy Industry Testosterone
More informationCommittee Approval Date: October 14, 2014 Next Review Date: March 2015
Medication Policy Manual Topic: Testosterone replacement therapy products: - Androderm, - Axiron, - Fortesta, - Striant, - Testim Gel, - Natesto, - Vogelxo Policy No: dru297 Date of Origin: March 15, 2013
More informationAre Men Losing Their Gonads?
Are Men Losing Their Gonads? Andre B. Araujo, Ph.D. Director, Epidemiology New England Research Institutes Watertown, MA 02472 USA aaraujo@neriscience.com NIA R01AG020727 Endocrine Society Annual Meeting
More informationAndrogens and CVD. Brandon Orr- Walker April 2014
Androgens and CVD Brandon Orr- Walker April 2014 Agenda What is normal physiology of Aging? Hypogonadism and disease If some is good is more becer? CVD safety Clinical features of Androgen Deficiency
More informationGUIDELINES ON MALE HYPOGONADISM
GUIDELINES ON MALE HYPOGONADISM G.R. Dohle (chair), S. Arver,. Bettocchi, S. Kliesch, M. Punab, W. de Ronde Introduction Male hypogonadism is a clinical syndrome caused by androgen deficiency. It may adversely
More informationDefinitions. Androgen deficiency. Clinical Hypogonadism* Low serum testosterone level Also called biochemical hypogonadism
MALE HYPOGONADISM Mark Sigman Krishnamurthi Family Professor and Chief of Urology Warren Alpert Medical School of Brown University Chief of Urology Rhode Island and the Miriam Hospitals 1 Topics What is
More informationDeficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study
Deficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study A M Dikobe, MB ChB, MMed (Psych) C W van Staden, MB ChB, MMed (Psych), MD, FCPsych,
More informationABCD position statement on the management of hypogonadal males with type 2 diabetes
PS ABCD hypogonadism_layout 1 10/11/2010 16:59 Page 1 ABCD position statement on the management of hypogonadal males with type 2 diabetes K Dhatariya*, D Nagi, TH Jones; on behalf of the Association of
More informationSEXUAL HEALTH & TESTOSTERONE -- DC ACP CHAPTER --
SEXUAL HEALTH & TESTOSTERONE -- DC ACP CHAPTER -- Michael S. Irwig, M.D. Associate Professor of Medicine, Director, Center for Andrology Division of Endocrinology & Metabolism Disclosures Pharma-Free Presentation
More informationCLS 306 Men and Women s Health Research Paper. Is testosterone therapy a safe and effective approach to treating major depression in adult males?
CLS 306 Men and Women s Health Research Paper Is testosterone therapy a safe and effective approach to treating major depression in adult males? Introduction: Major depressive disorder (MDD) is a debilitating
More informationTHE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION
THE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION Porav-Hodade Daniel 1, Coman Ioan 2, Boja Radu M 1, Todea Ciprian 1, Georgescu Carmen 2, Crisan
More informationMEASUREMENT OF TESTOSTERONE Roland R. Tremblay
MEASUREMENT OF TESTOSTERONE Roland R. Tremblay Learning Objectives 1. To understand that andropause is constituted by two structural levels and that the surface structure is amenable to diagnosis and treatment.
More informationTreatment of Males with Low Testosterone
Treatment of Males with Low Testosterone Noridian Healthcare Solutions, LLC Close Jump to Section... Please Note: This is a Proposed LCD. Proposed LCDs are works in progress and not necessarily a reflection
More informationMMM. Topic Diagnosis and Testosterone Replacement Therapy for Androgen Deficiency in the Aging Male (ADAM)
Dr Tan & Partners MMM Vol. 1 No. 3 Morbidity & Mortality Meeting 12 th December 2014 Topic Diagnosis and Testosterone Replacement Therapy for Androgen Deficiency in the Aging Male (ADAM) Introduction Androgen
More informationTestosterone deficiency establishing a biochemical diagnosis
Yonah Krakowsky, Ethan D. Grober Testosterone deficiency establishing a biochemical diagnosis Yonah Krakowsky, Ethan D. Grober Department of Surgery, Division of Urology, Mount Sinai & Women s College
More informationFocus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS
1 of 5 Focus Andropause: fact or fiction? Johan Wilson is an Auckland GP Introduction Androgen deficiency in the ageing male, or andropause, is being diagnosed with increased frequency. A growing body
More informationSex Hormone Testing by Mass Spectrometry
Sex Hormone Testing by Mass Spectrometry Robert L. Fitzgerald, PhD, DABCC Professor of Pathology University of California-San Diego San Diego, CA, 92161 rfitzgerald@ucsd.edu Learning Objectives After this
More informationX-Plain Low Testosterone Reference Summary
X-Plain Low Testosterone Reference Summary Introduction Testosterone is the most important male sex hormone. It helps the body produce and maintain adult male features. Low levels of testosterone affect
More informationThe Effect of Testosterone on Men With Andropause
Iran Red Crescent Med J. 2015 December; 17(12): e19406. Published online 2015 December 26. The Effect of Testosterone on Men With Andropause doi: 10.5812/ircmj.19406 Research Article Heshmatollah Sofimajidpour,
More informationTestosterone. Testosterone For Women
Testosterone Testosterone is a steroid hormone. Popular use of the term steroid leads people to believe that it signifies a drug that s illegal and abused by some body builders and other athletes. While
More informationTalk to your doctor about low testosterone
Talk to your doctor about low testosterone Maybe he doesn t find me attractive any more? Maybe he needs to lose some weight? Maybe he s lost his spark? Bayer Pharma AG Müllerstraße 178 13353 Berlin Germany
More informationCommon Endocrine Disorders. Gary L. Horowitz, MD Beth Israel Deaconess Medical Center Boston, MA
Common Endocrine Disorders Gary L. Horowitz, MD Beth Israel Deaconess Medical Center Boston, MA Objectives Describe the typical laboratory values for TSH and Free T4 in hypo- and hyperthyroidism Explain
More informationPrevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy
Prevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy International Society for Sexual Medicine 2014 Presenter: Felipe Borges
More informationABRAHAM MORGENTALER, MD, FACS TESTOSTERONE THERAPY FOR LIFE
Life Extension Magazine June 2010 By Julius Goepp, MD ABRAHAM MORGENTALER, MD, FACS TESTOSTERONE THERAPY FOR LIFE MAKING THE DIAGNOSIS With the growing number of scholarly articles on T replacement therapy
More informationJundishapur Journal Chronic Disease Care. 2013;2(3):41-46
Jundishapur Journal Chronic Disease Care. 2013;2(3):41-46 Jundishapur Journal Chronic Disease Care Quarterly Journal of Ahvaz Faculty of Nursing and Midwifery The andropause symptoms and its relationship
More informationTestosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E
Testosterone Treatment: Myths Vs Reality Fadi Al-Khayer, M.D, F.A.C.E The Biological Functions of Testosterone in Men Testosterone is essential to the musculoskeletal and metabolic systems throughout a
More informationThe Laboratory Diagnosis of Testosterone Deficiency
The Laboratory Diagnosis of Testosterone Deficiency DARIUS A. PADUCH, MD, PHD, ROBERT E. BRANNIGAN, MD, EUGENE F. FUCHS, MD, EDWARD D. KIM, MD, JOEL L. MARMAR, MD, AND JAY I. SANDLOW, MD ABSTRACT Evaluation
More informationTestosterone What to Measure & When
Testosterone What to Measure & When Godfrey C Moses, BSc, MSc,, PhD, FCACB Laboratory Director/Discipline Leader Chemistry, Gamma-Dynacare Medical Laboratories, London, ON (mosesg@gamma( mosesg@gamma-dynacare.com)
More informationCharacteristics of Testosterone Deficiency Syndrome in Men With Chronic Kidney Disease and Male Renal Transplant Recipients: A Cross-Sectional Study
Characteristics of Testosterone Deficiency Syndrome in Men With Chronic Kidney Disease and Male Renal Transplant Recipients: A Cross-Sectional Study M.G. Park, H.S. Koo, and B. Lee ABSTRACT Objectives.
More informationHypogonadism and Subnormal Total Testosterone Levels in Men with Type 2 Diabetes Mellitus
ORIGINAL ARTICLE Hypogonadism and Subnormal Total Testosterone Levels in Men with Type 2 Diabetes Mellitus Okeoghene Anthonia Ogbera 1, Chinenye Sonny 2, Fasanmade Olufemi 3 and Ajala Wale 4 ABSTRACT Objective:
More informationCARDIOMETABOLIC DISEASE AND TESTOSTERONE DEFICIENCY: IS THERE A LINK?
CARDIOMETABOLIC DISEASE AND TESTOSTERONE DEFICIENCY: IS THERE A LINK? Abraham Morgentaler, MD Founder and Director, Men s Health Boston Associate Clinical Professor of Urology Beth Israel Deaconess Medical
More informationHormone Replacement Therapy For Men Consultation Information. Round Rock Jollyville Westlake 512-231-1444 www.urologyteam.com.
Hormone Replacement Therapy For Men Consultation Information Round Rock Jollyville Westlake 512-231-1444 www.urologyteam.com Rev 05/13 Table of Contents Biological Aging and Hormones 2 As we age.... 3
More informationThe Role of Albumin in the Calculation of Free and Bioavailable Testosterone in Women with Hyperandrogenemia
The Role of Albumin in the Calculation of Free and Bioavailable Testosterone in Women with Hyperandrogenemia ANDREAS MUELLER, SUSANNE CUPISTI, HELGE BINDER, INGE HOFFMANN, MATTHIAS W. BECKMANN and RALF
More informationFebruary 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS
February 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS Calvin Hirsch, MD Professor of Clinical Internal Medicine (Geriatrics) UC Davis School of
More informationMale New Patient Package
Male New Patient Package The contents of this package are your first step to restore your vitality. Please take time to read this carefully and answer all the questions as completely as possible. Thank
More informationTESTOSTERONE The Future?
TESTOSTERONE The Future? Martin M. Miner MD Co-Director Men s Health Center The Miriam Hospital Clinical Professor of Family Medicine and Urology Warren Alpert School of Medicine of Brown University Providence,
More informationAge-related testosterone decline in a Brazilian cohort of healthy military men
Clinical Urology International Braz J Urol Vol. 37 (5): 591-597, September - October, 2011 Age-related testosterone decline in a Brazilian cohort of healthy military men Archimedes Nardozza Júnior, Sérgio
More informationFACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN
FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN General Pantarhei Bioscience B.V. is an emerging specialty pharmaceutical company with a creative approach towards drug development. The Company
More informationVaricocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD
Varicocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD Professor and Chairman, Department of Urology, Cleveland Clinic Lerner College of Medicine; Cleveland, Ohio Objectives: Review
More informationTestosterone for women, who when and how much?
Medicine, Nursing and Health Sciences Testosterone for women, who when and how much? Susan R Davis MBBS FRACP PhD Women s Health Research Program School of Public Health Monash University Melbourne Medicine,
More informationUnderstanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding
Controversies of testosterone replacement therapy in hypogonadal men with prostate cancer Samuel Deem, DO CULTURA CREATIVE (RF) / ALAMY Understanding the controversies surrounding testosterone replacement
More informationHistorical Basis for Concern
Androgens After : Are We Ready? Mohit Khera, MD, MBA Assistant Professor of Urology Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Historical
More informationAbout Andropause (Testosterone Deficiency Syndrome)
About Andropause (Testosterone Deficiency Syndrome) There are many myths, misconceptions and a general lack of awareness about this easily treated hormonal imbalance that research shows affects 20% of
More informationUs TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy
Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible
More informationNIKOLAI GONCHAROV 1, GULINARA KATSYA 1, ANNA DOBRACHEVA 1, ALEXANDER NIZHNIK 1, GALINA KOLESNIKOVA 1, VICTOR HERBST 2,& JÜRGEN WESTERMANN 2
The Aging Male, June 2006; 9(2): 111 122 Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic
More informationTestosterone Testing
20, 2012 Health Technology Assessment Testosterone Testing Final Evidence Report February 6, 2015 Health Technology Assessment Program (HTA) Washington State Health Care Authority PO Box 42712 Olympia,
More informationTestosterone Replacement Therapy and Prostate Risks: Where s the Beef?
Testosterone Replacement Therapy and Prostate Risks: Where s the Beef? Abraham Morgentaler, MD Division of Urology Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts, USA
More informationTwenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency a prospective study
ORIGINAL Article Vol. 38 (4): 512-518, July - August, 2012 Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency a prospective study Carlos
More informationTestosterone and Mood in Aging Men
Testosterone and Mood in Aging Men Stuart N. Seidman, MD a,c, *, Mark Weiser, MD b,c KEYWORDS Testosterone Partial androgen deficiency of aging male Hypothalamic-pituitary-gonadal axis Depression KEY POINTS
More informationMen s Health, Low Testosterone and Diabetes: Individualized Treatment and a Multidisciplinary Approach
Men s Health, Low Testosterone and Diabetes: Individualized Treatment and a Multidisciplinary Approach This white paper was developed by AADE and supported by an independent education grant from Solvay
More informationAging Well - Part V. Hormone Modulation -- Growth Hormone and Testosterone
Aging Well - Part V Hormone Modulation -- Growth Hormone and Testosterone By: James L. Holly, MD (The Your Life Your Health article published in the December 4th Examiner was a first draft. It was sent
More informationAnalog-Based Free Testosterone Test Results Linked to Total Testosterone Concentrations, Not Free Testosterone Concentrations
Clinical Chemistry 54:3 512 516 (28) Endocrinology and Metabolism Analog-Based Free Testosterone Test Results Linked to Total Testosterone Concentrations, Not Free Testosterone Concentrations Kristofer
More informationChapter 2 Pathophysiology of Late-Onset Hypogonadism and Risks and Benefits of Replacement Therapy
Chapter 2 Pathophysiology of Late-Onset Hypogonadism and Risks and Benefits of Replacement Therapy Peter Huat Chye Lim Introduction The testosterone molecule is depicted below (Fig. 2.1 ). Testosterone
More informationAndrogen deficiency in the aging male
Androgen deficiency in the aging male Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Male Reproduction and Urology The American Society for Reproductive
More informationDiurnal variation of testosterone (T) has been well documented
ORIGINAL ARTICLE Endocrine Care The Effect of Diurnal Variation on Clinical Measurement of Serum Testosterone and Other Sex Hormone Levels in Men Donald J. Brambilla, Alvin M. Matsumoto, Andre B. Araujo,
More informationLou Haenel, IV, DO Endocrinology October 3, 2015 TESTOSTERONE AND MALE HYPOGONADISM : DECIDING WHEN TO TREAT
Lou Haenel, IV, DO Endocrinology October 3, 2015 TESTOSTERONE AND MALE HYPOGONADISM : DECIDING WHEN TO TREAT Figure 1 The hypothalamic pituitary gonadal axis in men and the impact of testosterone therapy
More informationScientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation
Annex II Scientific conclusions and grounds for variation to the terms of the marketing authorisations subject to conditions and detailed explanation of the scientific grounds for the differences from
More informationHormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions
Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions IMPORTANCE OF HORMONE BALANCE Importance of Hormone Balance Help you live a long, healthy life Help you
More informationto the cases and then talk about management. But really who hasn t had a patient come into the
JODIE REIDER, MD 1 So I m going to begin with just presenting a few cases and then at the end of the talk we ll go back to the cases and then talk about management. But really who hasn t had a patient
More informationMonitoring of Prostate Cancer Patients: Guidelines and Current Practice
european urology supplements 6 (2007) 829 833 available at www.sciencedirect.com journal homepage: www.europeanurology.com Monitoring of Prostate Cancer Patients: Guidelines and Current Practice Laurent
More informationGrowth Hormone Deficiency
Growth Hormone Deficiency What is growth hormone deficiency? 1,2 Growth hormone deficiency is when your body doesn t make enough growth hormone. Growth hormone is one of many hormones made by the pituitary
More informationShira Miller, M.D. Los Angeles, CA 310-734-8864 www.shiramillermd.com. The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library
Shira Miller, M.D. Los Angeles, CA 310-734-8864 The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library 2 Outline What is hormone therapy? Why would healthy men and women need to think about
More informationTestosterone Replacement Therapies
Testosterone Replacement Therapies Policy Number: 5.01.23 Last Review: 7/2015 Origination: 7/2015 Next Review: 7/2016 Policy BCBSKC will provide coverage for testosterone replacement therapies when it
More informationMedication Policy Manual
Medication Policy Manual Topic: Non-preferred testosterone replacement therapy products (Androderm, Androgel, Aveed, Axiron, Fortesta, Natesto, Striant, Testim Gel, Testopel, Vogelxo, compounded testosterone
More informationUnderstanding the long-term risks and benefits of testosterone replacement
Understanding the long-term risks and benefits of testosterone replacement Nathan Hale, DO Samuel Deem, DO SHUTTERSTOCK.COM Male hypogonadism, also called andropause and androgen deficiency of the aging
More informationTestosterone and androgens in women
Testosterone and androgens in women http://womenshealth.med.monash.edu.au 1. Women normally produce testosterone 2. Changes in testosterone over the normal menstrual cycle 3. Changes in testosterone with
More informationCommentary: Who Is a Candidate for Testosterone Therapy? A Synthesis of International Expert Opinions
1 Commentary: Who Is a Candidate for Testosterone Therapy? A Synthesis of International Expert Opinions Abraham Morgentaler, MD,* Mohit Khera, MD, Mario Maggi, MD, and Michael Zitzmann, MD, PhD *Men s
More informationCorrelation of Aging and Body Mass Index with the Hypothalamic- Pituitary-Gonadal Axis Hormones in Men, with Diabetes Mellitus
6 The Open Andrology Journal, 2010, 2, 6-10 Open Access Correlation of Aging and Body Mass Index with the Hypothalamic- Pituitary-Gonadal Axis Hormones in Men, with Diabetes Mellitus Irinel Stanciu 1,3,
More informationA Guide to Extraction of Testosterone
Available online at www.sciencedirect.com Clinical Biochemistry 42 (2009) 484 490 Rapid determination of serum testosterone by liquid chromatography-isotope dilution tandem mass spectrometry and a split
More informationt!k EUROPEAN MEDICINES AGENCY TESTOSTERONE UPDATE
ACRUX (ACR) - ASX ANNOUNCEMENT 24 NOVEMBER 2014 EUROPEAN MEDICINES AGENCY TESTOSTERONE UPDATE The European Medicines Agency (EMA) released a statement regarding the use of Testosterone Replacement Therapy
More informationTestosterone & Testosterone Replacement Therapy
your PR.i.VATES Testosterone & Testosterone Replacement Therapy www.yourprivates.org.uk CONTENTS TESTOSTERONE & TRT Contents Introduction 3 Purposes of testosterone 4 How will I be affected by an orchidectomy?
More informationTestosterone Therapy in Adult Men with Androgen Deficiency Syndromes:
T h e E n d o c r i n e S o c i e t y s Clinical Guidelines Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline Authors: Shalender Bhasin,
More informationANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM
ANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM AT A GLANCE First published in July 2003 by Andrology Australia 4th Edition, December
More informationSymptoms of testosterone deficiency in early middle aged men
Symptoms of testosterone deficiency in early middle aged men Anna-Clara Spetz, Mats Fredrikson and Mats Hammar Linköping University Post Print N.B.: When citing this work, cite the original article. Original
More informationThe validity of androgen assays
The Aging Male, September 2007; 10(3): 165 172 The validity of androgen assays MALCOLM CARRUTHERS 1, TOM R. TRINICK 2, & MICHAEL J. WHEELER 3 1 Centre for Men s Health, London, 2 Department of Chemical
More informationTestosterone Therapy for Women
Testosterone Therapy for Women The Facts You Need Contents 2 INTRODUCTION: The Facts You Need... 3-4 CHAPTER 1: Testosterone and Women... 5-9 CHAPTER 2: Testosterone Therapy for Women... 10-14 CONCLUSION:
More informationT in Cheek: Buccal Testosterone as a New Treatment for Androgen Deficiency in Men
Reference Section T in Cheek: Buccal Testosterone as a New Treatment for Androgen Deficiency in Men a report by Bradley D Anawalt, MD, F ACP Associate Professor of Medicine, University of Washington and
More informationVitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department
More informationCOULD IT BE LOW TESTOSTERONE?
COULD IT BE LOW TESTOSTERONE? By Dr. Lauren M. Bramley For thousands of years women have been recognized for their sensitivity to hormones. PMS, post partum depression, menopause have long been plights
More informationHow To Diagnose Late Onset Hypogonadism
The clinical picture of male hypogonadism Professor Myles Spar Classic signs and symptoms Definitions Late onset hypogonadism (LOH, also referred to as age-associated testosterone deficiency [TDS]) is
More informationTESTOSTERONE (T) circulates in plasma nonspecifically
0021-972X/99/$03.00/0 Vol. 84, No. 10 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 1999 by The Endocrine Society A Critical Evaluation of Simple Methods for the Estimation
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationSubcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.
Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D., FACS Learning Objectives After reading and reviewing this
More informationMale Patient Questionnaire & History
Male Patient Questionnaire & History Name: Today s Date: (Last) (First) (Middle) Date of Birth: Age: Occupation: Home Address: City: State: Zip: E- Mail Address: May we contact you via E- Mail? ( ) YES
More informationTestosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
SPECIAL FEATURE Clinical Practice Guideline Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline Shalender Bhasin, Glenn R. Cunningham, Frances
More information